AtheroGenics, Inc. (NASDAQ: AGIX), a pharmaceutical company focused on the treatment of chronic inflammatory diseases, today announced that it expects to release its first quarter 2006 results of operations on Thursday, April 20, 2006, before the U.S. financial markets open.
